These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 23559476

  • 1. Identification and characterization of a linearized B-cell epitope on the pr protein of dengue virus.
    Song KY, Zhao H, Li SH, Li XF, Deng YQ, Wang HJ, Ye Q, Zhu SY, Jiang ZY, Zhang FC, Qin ED, Qin CF.
    J Gen Virol; 2013 Jul; 94(Pt 7):1510-1516. PubMed ID: 23559476
    [Abstract] [Full Text] [Related]

  • 2. [Mapping of the B Cell Neutralizing Epitopes on ED III of Envelope Protein from Dengue Virus].
    Lin Y, Wen K, Guo Y, Qiu L, Pan Y, Yu L, Di B, Chen Y.
    Bing Du Xue Bao; 2015 Nov; 31(6):665-73. PubMed ID: 26951013
    [Abstract] [Full Text] [Related]

  • 3. Identification of a novel infection-enhancing epitope on dengue prM using a dengue cross-reacting monoclonal antibody.
    Luo YY, Feng JJ, Zhou JM, Yu ZZ, Fang DY, Yan HJ, Zeng GC, Jiang LF.
    BMC Microbiol; 2013 Aug 29; 13():194. PubMed ID: 23987307
    [Abstract] [Full Text] [Related]

  • 4. Comprehensive mapping infection-enhancing epitopes of dengue pr protein using polyclonal antibody against prM.
    Luo Y, Guo X, Yan H, Fang D, Zeng G, Zhou J, Jiang L.
    Appl Microbiol Biotechnol; 2015 Jul 29; 99(14):5917-27. PubMed ID: 25822571
    [Abstract] [Full Text] [Related]

  • 5. Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins.
    Falconar AK.
    Arch Virol; 1999 Jul 29; 144(12):2313-30. PubMed ID: 10664386
    [Abstract] [Full Text] [Related]

  • 6. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
    Gromowski GD, Barrett AD.
    Virology; 2007 Sep 30; 366(2):349-60. PubMed ID: 17719070
    [Abstract] [Full Text] [Related]

  • 7. Natural immunogenic properties of bioinformatically predicted linear B-cell epitopes of dengue envelope and pre-membrane proteins.
    Nadugala MN, Jeewandara C, Jadi RS, Malavige GN, de Silva AM, Premaratne PH, Goonasekara CL.
    BMC Immunol; 2021 Nov 03; 22(1):71. PubMed ID: 34732126
    [Abstract] [Full Text] [Related]

  • 8. Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus.
    Gromowski GD, Barrett ND, Barrett AD.
    J Virol; 2008 Sep 03; 82(17):8828-37. PubMed ID: 18562544
    [Abstract] [Full Text] [Related]

  • 9. Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope.
    Metz SW, Thomas A, White L, Stoops M, Corten M, Hannemann H, de Silva AM.
    Virol J; 2018 Apr 02; 15(1):60. PubMed ID: 29609659
    [Abstract] [Full Text] [Related]

  • 10. Dengue Virus prM-Specific Human Monoclonal Antibodies with Virus Replication-Enhancing Properties Recognize a Single Immunodominant Antigenic Site.
    Smith SA, Nivarthi UK, de Alwis R, Kose N, Sapparapu G, Bombardi R, Kahle KM, Pfaff JM, Lieberman S, Doranz BJ, de Silva AM, Crowe JE.
    J Virol; 2016 Jan 15; 90(2):780-9. PubMed ID: 26512092
    [Abstract] [Full Text] [Related]

  • 11. Human monoclonal single-chain antibodies specific to dengue virus envelope protein.
    Saokaew N, Poungpair O, Panya A, Tarasuk M, Sawasdee N, Limjindaporn T, Chaicumpa W, Yenchitsomanus P.
    Lett Appl Microbiol; 2014 Mar 15; 58(3):270-7. PubMed ID: 24266517
    [Abstract] [Full Text] [Related]

  • 12. Dengue virus envelope domain III immunization elicits predominantly cross-reactive, poorly neutralizing antibodies localized to the AB loop: implications for dengue vaccine design.
    Li XQ, Qiu LW, Chen Y, Wen K, Cai JP, Chen J, Pan YX, Li J, Hu DM, Huang YF, Liu LD, Ding XX, Guo YH, Che XY.
    J Gen Virol; 2013 Oct 15; 94(Pt 10):2191-2201. PubMed ID: 23851440
    [Abstract] [Full Text] [Related]

  • 13. Identification and characterization of a virus-specific continuous B-cell epitope on the PrM/M protein of Japanese Encephalitis Virus: potential application in the detection of antibodies to distinguish Japanese Encephalitis Virus infection from West Nile Virus and Dengue Virus infections.
    Hua RH, Chen NS, Qin CF, Deng YQ, Ge JY, Wang XJ, Qiao ZJ, Chen WY, Wen ZY, Liu WX, Hu S, Bu ZG.
    Virol J; 2010 Sep 22; 7():249. PubMed ID: 20858291
    [Abstract] [Full Text] [Related]

  • 14. Synthetic B-Cell Epitopes Eliciting Cross-Neutralizing Antibodies: Strategies for Future Dengue Vaccine.
    Ramanathan B, Poh CL, Kirk K, McBride WJ, Aaskov J, Grollo L.
    PLoS One; 2016 Sep 22; 11(5):e0155900. PubMed ID: 27223692
    [Abstract] [Full Text] [Related]

  • 15. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
    Roehrig JT, Bolin RA, Kelly RG.
    Virology; 1998 Jul 05; 246(2):317-28. PubMed ID: 9657950
    [Abstract] [Full Text] [Related]

  • 16. Identification of Immunodominant Epitopes of Dengue Virus 2 Envelope and NS1 Proteins: Evaluating the Diagnostic Potential of a Synthetic Peptide.
    Singha S, Nath N, Sarma V, Barman K, Sharma GC, Saikia L, Baruah S.
    Mol Diagn Ther; 2024 Sep 05; 28(5):633-643. PubMed ID: 38980575
    [Abstract] [Full Text] [Related]

  • 17. Generation and characterization of a monoclonal antibody that cross-reacts with the envelope protein from the four dengue virus serotypes.
    León-Juárez M, García-Cordero J, Santos-Argumedo L, Romero-Ramírez H, García-Machorro J, Bustos-Arriaga J, Gutiérrez-Castañeda B, Sepúlveda NV, Mellado-Sánchez G, Cedillo-Barrón L.
    APMIS; 2013 Sep 05; 121(9):848-58. PubMed ID: 23331315
    [Abstract] [Full Text] [Related]

  • 18. Identification and selection of immunodominant B and T cell epitopes for dengue multi-epitope-based vaccine.
    Lim HX, Lim J, Poh CL.
    Med Microbiol Immunol; 2021 Feb 05; 210(1):1-11. PubMed ID: 33515283
    [Abstract] [Full Text] [Related]

  • 19. A human PrM antibody that recognizes a novel cryptic epitope on dengue E glycoprotein.
    Chan AH, Tan HC, Chow AY, Lim AP, Lok SM, Moreland NJ, Vasudevan SG, MacAry PA, Ooi EE, Hanson BJ.
    PLoS One; 2012 Feb 05; 7(4):e33451. PubMed ID: 22509258
    [Abstract] [Full Text] [Related]

  • 20. Structural and Functional Characterization of a Cross-Reactive Dengue Virus Neutralizing Antibody that Recognizes a Cryptic Epitope.
    Li J, Watterson D, Chang CW, Che XY, Li XQ, Ericsson DJ, Qiu LW, Cai JP, Chen J, Fry SR, Cheung STM, Cooper MA, Young PR, Kobe B.
    Structure; 2018 Jan 02; 26(1):51-59.e4. PubMed ID: 29249606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.